Shuttle Pharmaceuticals Holdings (SHPH) Long-Term Debt Issuances (2022 - 2025)
Shuttle Pharmaceuticals Holdings (SHPH) posted quarterly Long-Term Debt Issuances of $380540.0 for Q4 2025, up 300.0% year-over-year from $95135.0 in Q4 2024, and up 220.72% quarter-over-quarter from -$315214.0 in Q3 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Long-Term Debt Issuances (2022 - 2025) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Long-Term Debt Issuances history runs 4 years deep, the most recent figure standing at $380540.0 for Q4 2025.
- In Q4 2025, Long-Term Debt Issuances rose 300.0% year-over-year to $380540.0; the TTM figure through Dec 2025 stood at $190270.0 (up 105.53% YoY), while the FY2025 annual figure was $190270.0, up 218.55% from the prior year.
- Long-Term Debt Issuances for Q4 2025 stood at $380540.0, up from -$315214.0 in the prior quarter.
- The five-year high for Long-Term Debt Issuances was $546244.0 in Q1 2023, with the low at -$3.2 million in Q4 2023.
- The 4-year median for Long-Term Debt Issuances is $62472.0 (2025), against an average of -$203751.7.
- The sharpest annual moves came in 2023 and 2025: Long-Term Debt Issuances climbed 3.9% in 2023, then soared 300.0% in 2025.
- Shuttle Pharmaceuticals Holdings' Long-Term Debt Issuances stood at $822.0 in 2022, then sank by 395419.59% to -$3.2 million in 2023, then jumped by 94.14% to -$190270.0 in 2024, then jumped by 300.0% to $380540.0 in 2025.
- Business Quant data shows SHPH's Long-Term Debt Issuances at $380540.0 in Q4 2025, -$315214.0 in Q3 2025, and $63404.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Shuttle Pharmaceuticals Holdings | 1.87 Mn | 1.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 380,540.00 |
| Dec 31, 2025 | 380,540.00 |
| Sep 30, 2025 | -315,214.00 |
| Sep 30, 2025 | -315,214.00 |
| Jun 30, 2025 | 63,404.00 |
| Jun 30, 2025 | 63,404.00 |
| Mar 31, 2025 | 61,540.00 |
| Mar 31, 2025 | 61,540.00 |
| Dec 31, 2024 | -190,270.00 |
| Dec 31, 2024 | -190,270.00 |
| Dec 31, 2023 | -3.25 Mn |
| Dec 31, 2023 | -3.25 Mn |
| Jun 30, 2023 | 139,229.00 |
| Jun 30, 2023 | 139,229.00 |
| Mar 31, 2023 | 546,244.00 |
| Mar 31, 2023 | 546,244.00 |
| Sep 30, 2022 | 822.00 |
| Sep 30, 2022 | 822.00 |
| Mar 31, 2022 | 525,715.00 |
| Mar 31, 2022 | 525,715.00 |